Updates in Breast Cancer Screening and Diagnosis
Authors:
- 28 October 2024
- journal article
- review article
- Published by Springer Nature in Current Treatment Options in Oncology
- Vol. 25 (11) , 1451-1460
Abstract
Opinion Statement Breast cancer does not wait until a woman reaches her 50’s to strike. One in six cases occurs in women between the ages of 40 and 49 and breast cancer is the most prevalent cancer and the leading cause of cancer-related deaths among women under 50 in the United States (10% of breast cancer deaths), emphasizing the urgency of early detection (American Society. 2024). Duffy et al. highlight the vital role of mammography screening in younger women, showing that starting screening at 40 reduces breast cancer mortality, with a consistent absolute reduction over time (Duffy et al. Health Technol Assess. 24(55):1–24, 2020). By starting yearly mammograms at 40, we could see a remarkable 40% reduction in breast cancer deaths (Monticciolo et al. J Am Coll Radiol. 18(9):1280–8, 2021). Screening at age 40 also adds little to the burden of overdiagnosis that already arises from screening at age 50 and older. Comparing this to biennial screening between ages 50–74, yearly screening at 40 saves approximately 13,770 more lives annually according to a report by the American Cancer Society published in JAMA in 2015 (Oeffinger et al. JAMA. 314(15):1599–614, 2015). But it’s not just about saving lives; it’s also about preserving quality of life. Between ages 40 and 49, 12–15% of years of life lost are attributed to breast cancer, highlighting the impact on women’s lives. Early detection through screening can minimize these losses, ensuring more years spent with loved ones. It’s clear: starting mammograms at age 40 saves lives. We must prioritize early detection and make screening accessible to all women, regardless of age. This proactive approach can reduce the burden of breast cancer and pave the way for a healthier future for women everywhere.Keywords
This publication has 67 references indexed in Scilit:
- National Comprehensive Cancer Network Guideline Recommendations of Cancer Drugs With Accelerated ApprovalJAMA Network Open, 2023
- Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 womenCancer, 2020
- Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing ScreeningJAMA, 2020
- The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screeningCancer, 2018
- Breast Cancer Screening for Women at Average RiskJAMA, 2015
- Breast Cancer Screening Using Tomosynthesis in Combination With Digital MammographyJAMA, 2014
- Outcomes of Screening Mammography by Frequency, Breast Density, and Postmenopausal Hormone TherapyJAMA Internal Medicine, 2013
- Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast CancerJAMA, 2008
- Overview of Resistance to Systemic Therapy in Patients with Breast Cancer2007
- A breast cancer prediction model incorporating familial and personal risk factorsStatistics in Medicine, 2004